Skip to main content

Classic Cornelia de Lange syndrome with variant of unknown significance detected in NIPBL gene mutation: a case report



Cornelia de Lange syndrome is a relatively uncommon disorder associated with multiple congenital anomalies/mental retardation of unknown etiology with its incidence varying from 1:10,000 to 1:50,000 live births in different population groups without any known racial predilections. Main clinical features of this syndrome consist of distinctive dysmorphic facial appearance, growth retardation, developmental delay, mental retardation, hirsutism, and skeletal formation anomaly.

Case presentation

This case presents a variation of unknown significance in the NIPBL gene-exon 39, chr5:37048649T>A c.6635T>A (p.Val2212Glu) with clinical phenotype of Cornelia de Lange syndrome. Our patient belonged to South Indian origin with clinical features of synophrys, micrognathia, long smooth philtrum, and clinodactyly with bilateral simian crease.


Cornelia de Lange syndrome is a rare but well-characterized disorder, in which multiple systems of the body are affected. It is important that the treating physician ensures coordination of the diversiform aspects of care in both childhood and adulthood. Proper and timely diagnosis using next generation sequencing helps in management and possibility of prenatal diagnosis.


In 1916, Dr. W. Brachmann described the first case of this syndrome but in 1933 Cornelia de Lange, a Dutch pediatrician from Amsterdam was the first to report about two cases of this syndrome [1]. It is also called Brachmann de Lange syndrome, Amsterdam dwarfism, Bushy syndrome. There is variable incidence of this syndrome ranging from 1:10,000 to 1:50,000 live births with no racial predilection [2]. It is slightly more commonly seen in females when compared to males (F/M: 1.3/1). Most children with this syndrome cannot survive beyond 2 years. Pneumonia along with cardiac, respiratory, and gastrointestinal abnormalities is the main cause of death in these patients [2].

Cornelia de Lange syndrome (CDLS) is a multisystem developmental disorder with dysmorphic faces being the most diagnostic feature characterized by microcephaly, bushy eyebrows with synophrys, long eyelashes, hirsutism, smooth long philtrum, low set ears, thin lips, carp shaped mouth, and flared nostrils. Other clinical features are low birth weight, failure to thrive, prenatal and postnatal growth, mental and developmental retardation, learning difficulties, and failure to thrive [3, 4].

The overall CDLS phenotype involves a spectrum which includes the classic CDLS, non-classic CDLS as well as other syndromes phenotype (Coffin-Siris syndrome, Rubinstein-Taybi syndrome, Nicolaides–Baraitser syndrome) with almost identical clinical features [5]. CDLS is caused by pathogenic variants in genes involved in cohesion functioning. As per Kline et al. [5], till date, there is no individual with a classic CDLS phenotype in whom a variant gene without cohesion function has been definitely shown to be causative. All recognized, established, and obvious causes of CDLS can thus be labeled as cohesinopathies but not all cohesinopathies result in CDLS [5]. Most of the cases with CDLS are usually sporadic and 10% of total cases have chromosomal alterations like unbalanced chromosomal rearrangements [6], duplications, or partial trisomy of chromosome 3q26-27 [7]. Mutation in the Nipped-B-Like (NIPBL) gene is the most common and has been diagnosed in 26 to 56% cases as an etiological factor [8]. However, as per the first international consensus statement, first-line molecular diagnostic approach should be next-generation sequencing (NGS)-based screening—either gene panel, whole-exome sequencing (WES) or whole-genome sequencing (WGS)—including currently known CDLS genes (NIPBL, structural maintenance of chromosomes 1A (SMC1A), structural maintenance of chromosomes 3 (SMC3), RAD21 cohesin complex component (RAD21), Bromodomain-containing protein 4, (BRD4), histone deacetylase 8 (HDAC8), and ankyrin repeat domain 11 (ANKRD11) [5].

Here, we present a case of sporadic CDLS and its genetic workup.

Case presentation

A 2-year-old male child of South Indian origin (Kerala) was brought to the Department of Medical Genetics by the parents (Father—32 years/ Mother—28 years) for having progressive growth deficiency, childhood developmental delay, and mental retardation. He was the second male child born of a non-consanguineous marriage with uneventful antenatal period. He was born after pre-term caesarean section done at 33 weeks of gestation in view of previous caesarean section in labor (as per the hospital records and the discharge summary) with birth weight of 1.29 kg (small for gestational age) and cried immediately after birth. Their first child was a 5-years-old boy who appeared clinically normal. Both the parents also appeared clinically normal, and there three generations pedigree did not reveal any history of deformity/mental retardation. Anthropometric measurements of the child at presentation were as follows:

  • Weight: 7.6 kg (below 3rd percentile)

  • Height: 79 cm (below 3rd percentile)

  • Head circumference: 43 cm (below 3rd percentile)

Child had the following clinical features on examination:

Global developmental delay, mental retardation, growth retardation, dysmorphic face characterized by bushy eyebrows, dystichiasis, synophrys, long curly eyelashes, broad nasal root with flared nostrils, upturned nose, carp shaped mouth, thin bow-shaped lips with downturned corners, and long smooth philtrum was noted (Fig. 1a, b). The child also had short stubby fingers, bilateral simian crease, bilateral short 5th finger with clinodactyly (Fig. 1c), bilateral partial cutaneous syndactyly of 2nd and 3rd toe fingers, unilateral cryptorchidism, hirsutism, and craniosynostosis. Parents gave history of epilepsy and the child was on multiple antiepileptic medications. Child had not attained walking and sitting and milestones were delayed and mental retardation was seen.

Fig. 1

Clinical findings of the patient

As per the consensus, classic CDLS should have the score of 11 and above with presence of at least 3 cardinal features [5]. Our patient had cardinal features such as synophrys, long smooth philtrum, broad nasal root with upturned nostrils, bow-shaped lips with down turned corners with other suggestive features as mentioned above making the score of 15 (Table 1) which makes it classic CDLS.

Table 1 Clinical features of Cornelia de Lange syndrome and our case based on First International Consensus Statement, 2018 [5]

In view of dysmorphism and mental retardation, genetic work up was done after obtaining a written informed consent from the parents. The karyotype was 46, XY normal at 500 bands resolution by GTG banding. The parents were offered genetic counseling and were conveyed about the possibility of CDLS based on the clinical features. Child’s DNA was isolated from EDTA blood using commercial QIAGENE-QI Aamp-DNA mini kit and was subjected to targeted testing. The following genes were tested by Next generation sequencing: NIPBL, SMC1A, SMC3, RAD21, HDAC8, and ANKRD11. Next-generation sequencing-based screening of known CDLS gene showed a variant of unknown significance (VUS) in NIPBL gene. Molecular analysis report of the patient showed a VUS in Nipped-B-like protein (NIPBL) gene with heterozygous missense mutation (Fig. 2).

Fig. 2

Integrated genome viewer snapshot showing heterozygous mutation in NIPBL gene-EXON 39, chr5:37048649 T>A

NIPBL gene-exon 39, chr5:37048649T>A

This missense mutation replaces valine at codon 2212 by glutamic acid during transcription.

Although the mutation has been labeled as VUS, our in silico analysis showed it to be deleterious. The in silico predictions of this variant in our laboratory by ACMG (American College of Medical Genetics) guidelines [9, 10] shows it to be damaging by LRT (Likelihood Ratio Test), SIFT (Sort Intolerated From Tolerated), Mutation Taster and probably damaging by Polymorphism Phenotyping v2-Polyphen v2 (Table 2). Our search for the variant in databases like Clinvar, 1000Genome, and ExAC (Exome Aggregation Consortium) did not show any similar mutation. The parents were counseled about the disease condition, the genetic mutation, possible outcome, and prognosis. They were also offered mutation testing to rule out carrier status, and they were found to be negative for the same. Hence, the parents were explained that the mutation was probably a de novo/sporadic mutation with less than 1% recurrence risk although gonadal mosaicism can-not be ruled out.

Table 2 In-silico predictions (variant analysis report)*

CDLS is a relatively a rare entity associated with multiple congenital anomalies. Its cause and recurrent risk are unknown. This syndrome could occur due to inherited error of metabolism with no known environmental cause. Though autosomal dominant, autosomal recessive, and chromosomal abnormality have been suggested, most cases are sporadic in nature [1]. The distinct facial characteristics along with the physical features such as pre- and post-natal growth retardation, microcephaly, limb defects, hirsutism, and undescended testis helped in diagnosing CDLS easily in this patient.

Gupta and Goyal in 2005 and Sopori et al. in 2020 have each described a case report of CDLS from India, which was diagnosed based on striking characteristic phenotype and radiological features alone [4, 11]. With the advances in genetic testing, the association of NIPBL gene on chromosome 5 as the causative factor for CDLS was discovered followed by addition of other genes like SMC1A, SMC3, RAD21, HDAC8, and ANKRD11 in the list. NIPBL gene mutations have been found to be the most common causes of CDLS worldwide and contribute to approximately 50% of all CDLS cases [12]. The genetic knowledge helped in understanding CDLS as a spectrum of disorders involving classic CDLS, non-classic CDLS, and other phenotypes sharing limited signs of CDLS [5].


This case report delineates the importance of genetic testing and correlation of clinical phenotype and molecular genotype. Although this mutation has been reported VUS, the strong clinical features were suggestive of classical CDLS and the re-analysis of VUS mutation NIPBL gene-exon 39, chr5:37048649T>A suggests it to be disease causing. This emphasizes the advantage of reporting more number of population specific mutations in database like 1000genome, Clinvar, and ExAC for better understanding of genotype and phenotype.

Hence, it is necessary to have a genetic work-up of the disease by molecular analysis using next-generation sequencing (NGS) which helps in correct identification of mutation and thereby providing accurate results even in rare diseases. This further helps in providing genetic counseling and offering pre-natal diagnosis to anxious couples for future pregnancies.

Availability of data and materials

Data can be found in the archives of the Department of Medical Genetics, Lifeline Super Specialty Hospital.



Cornelia de Lange syndrome




Nipped-B-like protein


Structural maintenance of chromosomes 1A

SMC3 :

Structural maintenance of chromosomes 3

BRD4 :

Bromodomain-containing protein 4

RAD21 :

RAD21 cohesin complex component


Histone deacetylase 8


Ankyrin repeat domain 11


Next-generation sequencing


Whole-exome sequencing


Variant of unknown significance


Standard deviation


American College of Medical Genetics


Likelihood ratio test


Sort Intolerated From Tolerated

Polyphen v2:

Polymorphism phenotyping v2


Exome Aggregation Consortium


  1. 1.

    Badoe E (2006) Classical Cornelia de Lange syndrome. Ghana Med J 40(4):148–150

    PubMed  PubMed Central  Google Scholar 

  2. 2.

    Beck B, Fenger K (1985) Mortality, pathological findings and causes of death in the de Lange syndrome. Acta Paediatr Scand 74(5):765–769

    CAS  Article  Google Scholar 

  3. 3.

    Tayebi N (2008) Cornelia de Lange syndrome. Indian J Hum Genet 14(1):23–26

    Article  Google Scholar 

  4. 4.

    Gupta D, Goyal S (2005) Cornelia de Lange syndrome. J Indian Soc Pedod Prev Dent 23(1):38–41

    CAS  Article  Google Scholar 

  5. 5.

    Kline AD, Moss JF, Selicorni A, Bisgaard AM, Deardorff MA, Gillett PM et al (2018) Diagnosis and management of Cornelia de Lange syndrome: first international consensus statement. Nat Rev Genet 19(10):649–666

    CAS  Article  Google Scholar 

  6. 6.

    DeScipio C, Kaur M, Yaeger D, Innis JW, Spinner NB, Jackson LG et al (2005) Chromosome rearrangements in Cornelia de Lange syndrome (CdLS): report of a der (3) t (3; 12)(p25. 3; p13. 3) in two half sibs with features of CdLS and review of reported CdLS cases with chromosome rearrangements. Am J Med Genet A 137A(3):276–282

    Article  Google Scholar 

  7. 7.

    Wilson GN, Hieber VC, Schmickel RD (1978) The association of chromosome 3 duplication and the Cornelia de Lange syndrome. J Pediatr 93(5):783–788

    CAS  Article  Google Scholar 

  8. 8.

    Gillis LA, McCallum J, Kaur M, DeScipio C, Yaeger D, Mariani A et al (2004) NIPBL mutational analysis in 120 individuals with Cornelia de Lange syndrome and evaluation of genotype-phenotype correlations. Am J Hum Genet 75(4):610–623

    CAS  Article  Google Scholar 

  9. 9.

    Green RC, Berg JS, Grody WW, Kalia SS, Korf BR, Martin CL et al (2013) ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med 15(7):565–574

    CAS  Article  Google Scholar 

  10. 10.

    Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17(5):405–424

    Article  Google Scholar 

  11. 11.

    Sopori A, Bajaj M, Sharma J, Jangwal C (2020) Newborn with classical Cornelia de Lange syndrome: a rare case report. Indian J Case Rep 6(9):529–531

    Article  Google Scholar 

  12. 12.

    Li S, Miao H, Yang H, Wang L, Gong F, Chen S, Zhu H, Pan H (2020) A report of 2 cases of Cornelia de Lange syndrome (CdLS) and an analysis of clinical and genetic characteristics in a Chinese CdLS cohort. Mol Genet Genomic Med 8(2):e1066

    PubMed  PubMed Central  Google Scholar 

Download references


Authors are thankful to Medgenome Labs Private Limited, Bangalore, for helping us in targeted sequencing of our case. We are also thankful to Greeshma, T, Bioinformatician, for helping us in bioinformatics.


No external funding was received for this research project.

Author information




J.J.D conceived and designed the study. N.S.B and J.J.D performed clinical assessments, performed the experiments, contributed to data acquisition, analysis, and interpretation. N.S.B and P.S drafted the manuscript. All authors contributed to critical revision of the manuscript for intellectual content and final approval of the manuscript. All authors have read and approved final the manuscript.

Corresponding author

Correspondence to Sreelata B. Nair.

Ethics declarations

Ethics approval and consent to participate

The present study was approved by the hospital ethical committee and consented for publication (LLH/EC/017/SEP 2020).

Consent for publication

Written informed consent was obtained from the parents of the patient.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Desai, J.J., Nair, S.B. & Pappachan, S. Classic Cornelia de Lange syndrome with variant of unknown significance detected in NIPBL gene mutation: a case report. Egypt J Med Hum Genet 22, 28 (2021).

Download citation


  • Cornelia de Lange syndrome
  • Developmental delay
  • Dysmorphism
  • Missense mutation